Lupin Limited Stock price NSE India S.E.

Equities

LUPIN

INE326A01037

Pharmaceuticals

Market Closed - NSE India S.E. 08:02:00 2024-03-28 am EDT 5-day change 1st Jan Change
1,617 INR +1.05% Intraday chart for Lupin Limited +3.45% +22.21%
Sales 2024 * 199B 2.39B Sales 2025 * 217B 2.6B Capitalization 728B 8.74B
Net income 2024 * 19.8B 238M Net income 2025 * 23.09B 277M EV / Sales 2024 * 3.79 x
Net Debt 2024 * 25.18B 302M Net Debt 2025 * 10B 120M EV / Sales 2025 * 3.41 x
P/E ratio 2024 *
36.8 x
P/E ratio 2025 *
31.6 x
Employees 20,933
Yield 2024 *
0.44%
Yield 2025 *
0.52%
Free-Float 52.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.98%
1 week+0.25%
Current month-0.33%
1 month-0.04%
3 months+20.58%
6 months+42.59%
Current year+22.12%
More quotes
1 week
1 592.00
Extreme 1592
1 629.95
1 month
1 551.60
Extreme 1551.6
1 704.25
Current year
1 332.00
Extreme 1332
1 704.25
1 year
628.00
Extreme 628
1 704.25
3 years
583.00
Extreme 583
1 704.25
5 years
504.75
Extreme 504.75
1 704.25
10 years
504.75
Extreme 504.75
2 129.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 96-12-31
President - -
Director of Finance/CFO 59 07-08-12
Members of the board TitleAgeSince
Director/Board Member 74 15-10-26
Director/Board Member 69 21-01-27
Director/Board Member 50 95-12-31
More insiders
Date Price Change Volume
24-03-28 1,617 +1.05% 865 183
24-03-27 1,600 -0.93% 558,090
24-03-26 1,615 +0.41% 939,256
24-03-22 1,608 -0.21% 566,433
24-03-21 1,612 +3.12% 1,219,742

Delayed Quote NSE India S.E., March 28, 2024 at 05:33 am EDT

More quotes
Lupin Limited is a leading Indian pharmaceutical group. Its products are used to treat tuberculosis, diabetes, asthma, cardiovascular diseases, infections, etc. The group's activity is organized around 2 areas: - design and production of generic and brand-name formulations; - production of active pharmaceutical ingredients. At the end of March 2022, the group had 15 production sites India (12), the United States, Mexico and Brazil. Net sales break down geographically as follows: India (39.4%), the United States (34.1%) and other (26.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
1,598 INR
Average target price
1,510 INR
Spread / Average Target
-5.52%
Consensus
  1. Stock
  2. Equities
  3. Stock Lupin Limited
  4. Stock Lupin Limited - NSE India S.E.